The agency chose not to exercise much oversight over those that continued to compound as they were usually making small quantities of drugs for individual patients
Source: Forbes Health, 2026 Employer Coverage of GLP-1s Surges As of 2025, 43% of firms with over 5,000 workers now cover GLP-1 medications for obesity up from just 28% the prior year
Metabolomics in chronic kidney disease
In these cells, lithium, valproate, carbamazepine and lamotrigine increased the levels of the major antioxidant glutathione and the expression of glutamate-cysteine ligase, the rate-limiting enzyme in glutathione synthesis [97]
Studies demonstrate that periodic administration in aged animal models extends healthspan, improving physical performance, organ function, and resistance to age-related diseases (2, 3)
Current Issues In Molecular Continue reading One case study demonstrates the link between insulin and hair growth